BridgeMD
New treatment option for Plantar Fascitis
Official title SakuraBead Used as Resorbable Embolic for Plantar Fascia Embolization
ClinicalTrials.gov ID: NCT07241884
What this study is testing
- What it's testing
- This is a prospective, single center, double arm, randomized, unmasked, First in Human study that aims to evaluate the safety and effectiveness of SakuraBead™ resorbable embolization microspheres in adult patients suffering from pain secondary to plantar fasciitis.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Patient is able and willing to provide written informed consent, and
- Age 18 to 75 years (inclusive), and
- Clinical diagnosis of PF with proximal plantar fascia thickness greater than 4mm and areas of hypoechogenicity.
You likely can't join if
- Acute internal derangement of the foot including acute meniscal, ligament or bone injury, or
- Sensory or motor neuropathy of the feet, or
- Heel pain caused by stress fractures, nerve entrapment, or inflammatory conditions such as arthritis, gout, or bursitis, or
- Prior surgical repair or plantar fascia rupture in the involved foot, or
- Local infection in either foot, or
- Contraindication to MRI, or
See the full eligibility criteria
- Patient is able and willing to provide written informed consent, and
- Age 18 to 75 years (inclusive), and
- Clinical diagnosis of PF with proximal plantar fascia thickness greater than 4mm and areas of hypoechogenicity.
- Acute internal derangement of the foot including acute meniscal, ligament or bone injury, or
- Sensory or motor neuropathy of the feet, or
- Heel pain caused by stress fractures, nerve entrapment, or inflammatory conditions such as arthritis, gout, or bursitis, or
- Prior surgical repair or plantar fascia rupture in the involved foot, or
- Local infection in either foot, or
- Contraindication to MRI, or
- Active pregnancy as demonstrated by urine or serum β-hCG or lactating female
- Unable to provide informed consent or comply with the conditions of the study, or
- At the discretion of the Principal Investigator
The study team makes the final eligibility decision.
Where it's taking place
- Tashkent, Uzbekistan, Uzbekistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tashkent, Uzbekistan, Uzbekistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.